Company news
ADVANZ PHARMA Corp. Limited news in 2020
ADVANZ PHARMA Corp. Limited's news releases, calls and decks from 2020, newest first.
ADVANZ PHARMA Corp. Limited Announces Third Quarter 2020 Results
November 6, 2020
ADVANZ Pharma Corp. Limited ("ADVANZ" or the "Company") - Formal Sale Process
October 23, 2020
ADVANZ PHARMA Corp. Limited Announces Release Date for Third Quarter 2020 Results
October 23, 2020
ADVANZ PHARMA Corp. Limited Announces Second Quarter 2020 Results
August 12, 2020
ADVANZ PHARMA Corp. Limited Announces Release Date for Second Quarter 2020 Results
July 29, 2020
ADVANZ PHARMA Corp. Limited Announces Results of Annual Meeting of Shareholders
June 17, 2020
Correvio Provides Update Pursuant to BCI 51-515 - Temporary Exemption from Certain Corporate Finance Requirements
June 15, 2020
ADVANZ PHARMA Corp. Limited Closes Acquisition of Specialty Pharmaceutical Company Correvio Pharma Corp.
May 27, 2020
ADVANZ PHARMA Corp. Limited Announces First Quarter 2020 Results
May 13, 2020
ADVANZ PHARMA Corp. Limited Announces Release Date for First Quarter 2020 Results
April 29, 2020
ADVANZ PHARMA Corp. Limited Closes Acquisition of the Rights to a Portfolio of Alprostadil Products from UCB S.A. for $83 Million
April 1, 2020
ADVANZ PHARMA Corp. Limited Completes Voluntarily Delisting from the Toronto Stock Exchange
March 27, 2020
ADVANZ PHARMA Corp. Limited Announces Fourth Quarter and 2019 Results
March 25, 2020
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
March 16, 2020
ADVANZ PHARMA Corp. Limited Announces Release Date for Fourth Quarter and 2019 Results
March 11, 2020
ADVANZ PHARMA Corp. Limited to Voluntarily Delist from the Toronto Stock Exchange
March 10, 2020
ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million
March 6, 2020
ADVANZ PHARMA Corp. Limited Comments on CMA Supplemental Statement of Objections Related to Hydrocortisone Tablets
February 12, 2020
ADVANZ PHARMA Announces Changes to its Board of Directors and Completion of its Continuance to Western Europe
January 8, 2020